Ethnic/racial determinants of glycemic markers in a UK sample-Reference-Cited by-同舟云学术

Ethnic/racial determinants of glycemic markers in a UK sample

Published:2015-01-07 Issue:4 Volume:52 Page:687-692
ISSN:0940-5429
Container-title:Acta Diabetologica
language:en
Short-container-title:Acta Diabetol

Author:

Shipman Kate Elizabeth,Jawad Mohammed,Sullivan Katie Marie,Ford Clare,Gama Rousseau

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00592-014-0703-y.pdf

Reference25 articles.

1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose) (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378:31–40. doi: 10.1016/S0140-6736(11)60679-X

2. World Health Organization (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. WHO/NMH/CHP/CPM/11.1. World Health Organization, Geneva

3. Hwang YC, Ahn HY, Park SW, Park CY (2014) Apolipoprotein B and non-HDL cholesterol are more powerful predictors for incident type 2 diabetes than fasting glucose or glycated hemoglobin in subjects with normal glucose tolerance: a 3.3-year retrospective longitudinal study. Acta Diabetol 51(6):941–946. doi: 10.1007/s00592-014-0587-x

4. Cardoso CRL, Leite NC, Ferreira MT, Salles GF (2014) Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study. Acta Diabetol. doi: 10.1007/s00592-014-0592-0

5. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T, Barrett-Connor E, Diabetes Prevention Program Research Group (2007) Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program. Diabetes Care 30:2453–2457

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Role Might There Be for Continuous Glucose Monitoring in the Assessment of Diabetes Risk?;Diabetes Technology & Therapeutics;2023-06-01

2. Continuous Glucose Monitoring Impact and Implications of Real-World Evidence: Past, Present, and Future;Diabetes Technology & Therapeutics;2023-06-01

3. Past, Present, and Future of Continuous Glucose Monitors;Diabetes Technology & Therapeutics;2023-06-01

4. Use of Retrospective Continuous Glucose Monitoring Data Is Underrated and Underused;Journal of Diabetes Science and Technology;2022-01-19

5. Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology;Diabetes Research and Clinical Practice;2020-12